Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Sysmex and MolecularMD have signed a non-exclusive collaboration agreement focused on the development and commercialization of companion diagnostics for precision medicine. As part of the collaboration, the firms said they will integrate the

Greiner Bio One International (Kremsmnster, Obersterreich, Austria) has launched the innovative VACUETTE SAFELINK tube holder with male luer lock that facilitates quick and easy blood collection. The tube offers simple handling and can be us

The global point of care (POC) urinalysis market is projected to grow at a CAGR of more than 3% over the 2018-2022 period, driven mainly by the rising prevalence of nephropathic disorders and urinary tract infections (UTIs) which is generati

Danaher today initiated its earning outlook for 2019, saying EPS is anticipated to be in the range of $4.02 to $4.12. On a non-GAAP basis, EPS is expected to be in the range of $4.75 to $4.85, which assumes non-GAAP core revenue growth of ab

The New York State Department of Health has approved a whole-genome and transcriptome sequencing oncology test developed by the New York Genome Center for clinical testing. According to NYGC, it is the first whole-genome cancer test to rece

Agilent technologies has announced a new expansion of its Little Island facility in cork, Ireland.The facility park will be dedicated to developing advanced technologies for real-time analysis of living cells. The expanded facility includes

Mesa Biotech recently said that the US Food and Drug Administration has cleared and CLIA-waived the companys Accula RSV respiratory syncytial virus test for diagnostic use in both children and adults. According to the San Diego-based firm,

Novacyt announced recently that its molecular testing division, Primerdesign, has inked an exclusive supply agreement with Genesis Diagnostics. Primerdesign will develop and supply 384-well plate molecular assay panels in the areas of respi

Stilla Technologies announced recently that it has completed a 16 million ($18.3 million) Series A financing round led by Illumina Ventures. Kurma Partners, LBO France, BNP Paribas Dveloppement, Paris Saclay Seeds, and Idinvest Partners als

Q: What did you do with the other embryos? Were they implanted? A: There are seven couples but the clinical trial is on hold due to the current situation. Q: What did you to get feedback on the clinical trial design? What was the scope of th